RYAN is a leading international specialty insurance firm headquartered in Chicago and listed on the NYSE since its July 2021 initial public offering. Founded by insurance industry veteran Patrick G. Ryan, the company acts as a wholesale broker and managing underwriter, helping retail brokers, agents, and carriers place complex or hard-to-place risks.
The business operates across three principal specialties: Wholesale Brokerage, Binding Authority, and Underwriting Management. Its fee-based model, deep specialty expertise, and high producer retention have supported consistent organic growth, positioning the firm as one of the most prominent pure-play specialty intermediaries in the market. Investors follow RYAN closely for its growth trajectory, margin discipline, and capital-allocation decisions. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over the last 30 days, RYAN advanced from a closing price of $38.00 to approximately $46.89, a gain of about 23%. The move was concentrated in the second half of October and early November, as shares pushed through the $44 and $47 levels on above-average volume before consolidating near the high end of the range.
The longer three-month picture tells a more volatile story. Starting from roughly $42.82 in mid-August, the stock initially softened through September, touching a low near $36 in late September before a sharp recovery. As a result, the trailing-quarter gain of about 9.5% reflects a V-shaped rebound rather than a steady climb, with most of the appreciation occurring after third-quarter earnings were released.
The primary catalyst was the company's third-quarter 2026 earnings report, released on October 29. Total revenue rose 4.7% to $790.0 million on organic growth of 4.0%, and adjusted diluted EPS increased 8.5% to $0.51, modestly ahead of analyst consensus. Net income climbed 40.6% to $88.0 million, while adjusted EBITDAC grew 3.8% to $244.4 million.
Investor sentiment also benefited from management's capital-return activity. The company repurchased 3.5 million shares for $150 million during the quarter and an additional 1.3 million shares for $50 million in October, bringing year-to-date capital returned to shareholders to roughly $573 million. The board also declared a $0.13 quarterly dividend.
Following the report, several analysts adjusted their views. Wells Fargo raised its price target to $46 with an Equal Weight rating, while firms including UBS and RBC maintained constructive ratings. Management's improved full-year margin guidance and progress on AI-related product initiatives — such as expanded capacity for GPU coverage — provided additional support to the narrative.
Across the trailing three months, RYAN's performance reflected two distinct phases. In August and September, shares pulled back as investors weighed softer property pricing, heightened competition, and concerns about decelerating organic growth against a tough prior-year comparison. The stock bottomed near the mid-$36 area in late September.
The recovery that followed was driven by a combination of solid quarterly execution, consistent buybacks, and reassurance from management that organic growth guidance remained intact. New business wins, strong renewal retention, and expanding relationships in specialty and E&S markets helped offset pricing headwinds, restoring confidence and lifting the stock back toward the levels seen earlier in 2026.
Looking ahead, investors are likely to focus on pricing dynamics across property and casualty lines, where management has signaled continued property pricing declines and broader competitive pressure. Fourth-quarter results will test whether organic growth can hold toward the higher end of the mid-single-digit range amid these headwinds.
Other factors to monitor include the pace of share repurchases, progress on AI-related product launches, and any pickup in M&A activity that management has indicated could accelerate. Macroeconomic conditions, interest-rate movements, and shifts in the specialty and E&S insurance markets will also shape the outlook. As always, these considerations are informational and do not constitute investment advice. I’m watching this closely with help from Tickeron’s AI Trend Prediction Engine to stay on top of potential shifts.
In my research process, I frequently review Tickeron’s Trending AI Robots to see how automated strategies are positioning around names like this. The page offers a curated look at top-performing bots across various strategies and timeframes, which helps me understand algorithmic sentiment without replacing my own analysis. It serves as a useful supplement when evaluating how different models are navigating current market conditions for RYAN.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Stochastic Oscillator for RYAN moved out of overbought territory on November 13, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 61 similar instances where the indicator exited the overbought zone. In 46 of the 61 cases the stock moved lower. This puts the odds of a downward move at 75%.
The 10-day RSI Indicator for RYAN moved out of overbought territory on November 09, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In 24 of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at 71%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RYAN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.
RYAN broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on October 13, 2026. You may want to consider a long position or call options on RYAN as a result. In 50 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 60%.
RYAN moved above its 50-day moving average on October 16, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for RYAN crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.
Following a +5.53% 3-day Advance, the price is estimated to grow further. Considering data from situations where RYAN advanced for three days, in 197 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 137 of 249 cases where RYAN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. RYAN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 82 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RYAN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: RYAN's P/B Ratio (11.438) is slightly higher than the industry average of (2.681). RYAN has a moderately high P/E Ratio (61.192) as compared to the industry average of (19.012). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.322). Dividend Yield (0.011) settles around the average of (0.039) among similar stocks. P/S Ratio (1.707) is also within normal values, averaging (2.968).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InsuranceBrokersServices